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ABSTRACT 
Aim. In this paper we describe a trial protocol used to assess feasibility related to: study 
administration (recruitment, randomisation, retention, compliance, eligibility criteria, 
suitability of protocol instructions and data collection questionnaires); resource and data 
management (suitability of site, time and budget allocation, management of personnel and 
data); intervention fidelity (treatment dose, violations) and effect size. 
Background. Pressure injury can lead to increases in hospital length of stay and cost. The 
sacrum is identified as one of the most common anatomical pressure injury sites for 
hospitalised patients. Silicone foam border dressings have been proposed as one strategy to 
reduce pressure injury incidence, however rigorous testing of benefit in a general medical-
surgical population is required. 
Design. Randomised controlled trial. 
Methods. Eighty patients will be recruited after assessment of high risk of pressure injury in 
a large tertiary hospital in south-east Queensland, Australia. Eligible, consenting participants 
will be randomly allocated to either a control group (routine care) or an intervention group 
(routine care and a sacral prophylactic dressing). The primary outcomes comprise feasibility 
criteria as identified above. The secondary measure is the presence and severity of sacral 
pressure injury via blind assessment of digital photographs. Hospital and university ethics 
approval was received in October 2013. 
Discussion. Prophylactic dressings applied to the sacrum may be an effective method for 
reducing pressure injury in high risk general medical-surgical patients. However more 
rigorous studies to confirm benefit are required.  This pilot study will determine the 
feasibility and effect size to inform a larger randomised controlled trial. 
Keywords acute care, prevention, pressure injury, sacrum, silicone foam border dressing, 
nursing, pilot study, feasibility  
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Trial registration Registered with the Australian and New Zealand Clinical Trials - 
ACTRN12613001328763 http://www.ANZCTR.org.au/ACTRN12613001328763.aspx 
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SUMMARY STATEMENT 
 
Why is this study needed? 
 Previous studies report prophylactic dressings are effective in reducing PI in intensive 
care/high dependency patient populations. 
 Findings from published studies are inconsistent; this may be due to the observational 
focus of research and/or design limitations related to limited allocation concealment, 
blind assessment and a lack of control of relevant confounding factors. 
 This is the first randomised controlled trial to test allocation concealment and blind 
assessment of PI using photography in a hospitalised general medical-surgical patient 
population. 
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INTRODUCTION 
Acutely and chronically ill patients are at high risk of developing pressure injuries 
(PI) during their hospitalisation (Allman et al. 1999, Brindle & Wegelin 2012, Chaiken 2012, 
Jenkins & O'Neal 2010, Meyers 2010). Hospital acquired PI may cause pain, discomfort and 
immobility for patients, increase the risk of infection, complications and prolong the length of 
hospital admission at considerable cost (Allman et al. 1999, VanGilder et al. 2009).  
Pressure injuries continue to impact patients and health services. According to recent 
Australian data, the rate of hospital acquired PI was between 7.4-17.4% (Mulligan et al. 
2011).  In the state of Queensland, the rate of hospital acquired PI in 2011 was 8.8% for all 
patients and 15.1% for patients with restricted mobility (Centre for Healthcare Improvement 
2012).  Although current data regarding the cost of PI per patient are not available Graves, 
Birrell & Whitby (2005) predicted the cost of PI in Australian public hospitals in 2001-02 
was AU$285 million with 398,000 bed days used. In the UK the total annual cost of PI 
management reported by Bennett and colleagues (2004) was GB£1.4-2.1 billion equating to 
4% of total healthcare expenditure, while the average cost of a PI in the United States’ health 
care system has been estimated at between US$37,000 to $70,000 per patient (Armstrong et 
al. 2008, Weir 2009). The Queensland Government recently introduced a system of financial 
penalty for severe PI with stage 3 PI costing individual health services AU$30,000 and 
$50,000 for identified stage 4 PI ( Miles et al. 2013). Prevention of PI therefore represents a 
national and international priority in terms of patient outcome and economic efficiency. 
 
Background 
The sacrum is identified as one of the most common anatomical pressure injury sites 
(Brindle & Wegelin 2012, Centre for Healthcare Improvement 2012, Chaiken 2012, Walsh et 
al. 2012). Prevention strategies such as the use of prophylactic silicone foam border dressings 
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in very high risk critical care or high dependency patients have resulted in a reduction in their 
incidence (Brindle & Wegelin 2012, Chaiken 2012, Walsh et al. 2012, Santamaria et al. 
2013). However these results may be difficult to replicate in a hospitalised general medical-
surgical population due to their focus on intensive care/high dependency settings and, 
unreliable due to their observational design and/or methodological limitations related to 
deficient allocation concealment, blind assessment and lack of control of confounding factors 
(Schulz 2008, Brindle & Wegelin 2012, Chaiken 2012, Santamaria et al. 2013, Walsh et al. 
2012). Furthermore, the authors of a recent Cochrane Review who examined dressings and 
topical agents used in the prevention of PI recommended more data about the effectiveness of 
silicone foam bordered dressings was required (Moore & Webster 2011). Thus more rigorous 
testing of the dressing in a general medical-surgical population is required. 
 
THE STUDY 
Aims 
The objective for this pilot study is to evaluate the feasibility of undertaking a RCT to 
assess effectiveness against pre-defined criteria. Pilot studies are not suitable for hypothesis 
testing (Leon et al. 2011). Rather they are useful in evaluating the feasibility of an 
intervention as a pre-requisite strategy for a larger study in relation to: study administration 
(recruitment processes including refusals, randomisation, retention rates, compliance, 
eligibility criteria, suitability of protocol instructions and data collection questionnaires); 
resource and data management considerations (related to suitability of site, time and budget 
allocation; management of personnel and data); intervention fidelity (comprising treatment 
dose, effect and identification of violations) and effect size (Thabane et al. 2010, Lancaster et 
al. 2004, Leon et al. 2011). It is therefore essential pilot studies are conducted with the same 
rigor and scrutiny as larger trials to avoid bias and misleading results (Arnold et al. 2009). 
7 
 
The specific aims of this pilot phase are to: 
1. Assess the feasibility of conducting a RCT using pre-determined feasibility criteria 
comprising recruitment, retention, management of personnel and data and 
intervention fidelity; 
2. Use pilot data to refine the intervention protocol and research strategies; 
3. Test the effectiveness of blind assessment and data collection; 
4. Enable sample size estimations for a larger RCT (Leon et al. 2011). 
 
Design 
The researchers will adhere to the Good Clinical Practice and Consolidated Standards 
of Reporting Trials (CONSORT) guidelines for parallel group trials (Moher et al. 2010) and 
test feasibility of using an RCT design over 8-12 months. The study period is realistic due to 
the high level of patient acuity in the study venue and the often rapid onset of PI in acutely ill 
patients (Gefen 2008). All participants assessed as being high to very high risk of PI will be 
randomly assigned to either the routine care or dressing group, or routine care group and 
receive routine care as per hospital policy, regardless of their allocation. In the participating 
health care facility, routine care for patients assessed as having a high risk of PI consists of 
regular skin observation and nursing care via use of a pressure redistribution overlay on a 
standard mattress, or removal of a standard mattress and replacement with a pressure 
redistributing mattress, possible multi-disciplinary review and second hourly repositioning. 
 
Participants 
 Non-probability consecutive sampling will include all eligible adult patients admitted 
to specific admission entry points and continue until 80 patients are randomised. Patients who 
meet the following inclusion criteria will be eligible for recruitment into the study: 
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 ≥18 years of age (the study venue is an adult-focused tertiary health facility); 
 Able to provide written informed consent either in person or via their family 
member or legal guardian (National Health and Medical Research Council 2007). 
Approval to seek proxy consent has been granted by the Queensland Civil and 
Administrative Tribunal. 
 Assessed as being at high risk or greater of PI (as per a risk assessment score of 
15+ using the Waterlow Scale at admission entry points into the general medical-
surgical context as per hospital policy. 
 Expected hospital length of stay ≥72hrs following recruitment; 
Exclusion criteria include: 
 Suspected or actual spinal injury which prevents the patient being repositioned; 
 Lower back surgery (lumbar spine) which prevents the application of a sacral 
dressing; 
 Existing sacral PI, injury or allergy in the sacral area at the time of hospital 
admission; 
 Faecal incontinence at the time of hospital admission; 
 Unable to speak or understand English with no interpreter present. 
 
Outcomes 
While the aims of this study are to test the feasibility of the protocol and related 
processes to inform a larger trial, the main outcome of the program of research is to reduce 
the prevalence and severity of PI in high risk hospitalised patients. The National Pressure 
Ulcer Advisory Panel (NPUAP), European Pressure Ulcer Advisory Panel (EPUAP) pressure 
injury and staging classification system (National Pressure Ulcer Advisory Panel (NPUAP) 
2009) (as reported in the Pan Pacific Clinical Practice Guideline for the Prevention and 
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Management of Pressure Injury (Australian Wound Management Association 2012), will be 
used to guide the assessment of PI. Assessment of patients in both groups will be conducted 
by a blind nurse assessor via high resolution photographs and occur every third day 
coinciding with dressing removal in intervention participants (Walsh et al. 2012, Brindle & 
Wegelin 2012, Chaiken 2012, Santamaria et al. 2013) and/or on discharge from the ward.   
Secondary endpoints are identified in Table 1. 
 
Study process 
General medical-surgical patients will be screened for eligibility into the study by the 
Research Nurse at specified admission entry points. Routine PI risk assessment using the 
Waterlow Scale will be conducted by nursing staff when patients are admitted to the facility 
and thereafter, as per hospital policy. The Waterlow assessment relies on the rating of 8 
categories including build and weight for height, visual assessment of the skin, age, gender, 
continence, mobility, measure of malnutrition and several ‘special risk factors’ (tissue 
malnutrition, neurological deficits, major surgery and certain medications) (Webster et al. 
2010a). A score of 15 or above is considered the cut-off point for high risk of PI and a score 
of 20 or above as very high risk (Webster et al. 2010a). In the study site, patents assessed as 
high risk of PI have specific interventions provided to decrease the risk of PI; these are 
outlined in the hospital wide Risk Assessment Management Flowchart. Furthermore, all 
registered and enrolled nurses at the study venue are required to undertake annual pressure 
injury assessment training using the National Database of Nursing Quality Indicators 
(NDNQI) PI classification system. 
 Entry points to the study will be via the Surgical Care Unit (SCU), the Emergency 
Department (ED) or the participating medical and surgical wards. Patients are increasingly 
admitted to wards via ED in short time periods due to the National Emergency Access Target 
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(National Health Performance Authority 2012). The aim of the strategy is to ensure patients 
presenting to an Australian public hospital ED will either physically leave the ED for 
admission to hospital, be referred to another hospital for treatment or be discharged home 
within 4 hours. 
To contain the number of wards participating in this feasibility study only orthopedic 
patient cases and medical admissions will be screened and approached. Screening at the point 
of admission will ensure patients are assessed for risk of PI and study eligibility and then 
randomised to either the control or intervention group on admission to hospital. Prospective 
participants or their family member or legal guardian will be told about the study at an 
appropriate time during their admission and provided with sufficient time to read the 
information, consider their participation and provide informed consent. 
 
Intervention 
When consented and randomly allocated to a study group, recruited  patients will have 
demographic and health status characteristics recorded including age, gender, diagnosis or 
surgery, source of admission, mobility status, body mass index, health comorbidities, current 
smoking status, Waterlow score, existing PI (other than sacral) and history of PI. A high 
resolution photograph of each participant’s sacrum will be taken at this point as a baseline 
reference point. Each recruited patient’s name and hospital information (date of birth, unique 
record number and contact phone number) will be detailed in a separate document 
(participant key) and only be available to the Research Nurse to ensure patient 
confidentiality. 
If allocated to the ‘routine care and dressing group’ the Research Nurse will apply a 
silicone foam border dressing to the patient’s sacrum and document the participants consent 
and study enrollment in their health record. Patients allocated to the routine care group will 
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continue to receive routine care, as per hospital policy.  All patients enrolled in the study will 
have their sacrum/dressing assessed at least once a day and preferably each shift (every 8 
hours) by the Research Nurse or RNs caring for the patient as per hospital policy 
recommendations. For participants in the dressing group, the dressing will be assessed at least 
once a day and replaced every 3 days or sooner if it becomes loose or soiled. The sacral 
dressing will also be removed in instances of skin reaction, faecal incontinence and patient-
rated discomfort. Skin reaction will be reported via the standard hospital incident reporting 
process as an adverse event. The dressings will continue to be used for intervention group 
patients until their discharge from the study ward or until the patient is mobilising 
independently, whichever is sooner. 
The dressings being used are specifically designed and shaped for the sacral area. 
They are comfortable and hypoallergenic according the manufacturer’s advice. The silicone 
layer ensures that the dressing can be changed without damaging the wound or surrounding 
skin or exposing the patient to additional pain thereby minimising the risk for maceration. 
Furthermore, the dressing can be lifted and adjusted or removed and reapplied to allow for 
regular observation, without losing its adherent properties. The dressing is also showerproof 
to allow it to remain insitu for several days (Molnlycke Health Care). There are several 
reports of quality improvement projects where sacral foam dressings to prevent PI have been 
changed every 3 days or twice a week safely and with good effect (Brindle 2010, Brindle & 
Wegelin 2012, Chaiken 2012, Walsh et al. 2012). Therefore this feasibility study will allow, 
where possible, prophylactic silicone foam dressings to remain intact for up to three days 
before replacement.  
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Sample size 
A total of 80 patients (40 per group) will be recruited and randomised to the study. 
Although this number will be insufficient to determine effect, it will be appropriate to 
determine feasibility and sufficient to yield estimate of effect size to inform planning of a 
larger trial (Arnold et al. 2009, Hertzog 2008, Leon et al. 2011, Thabane et al. 2010). Figure 
1 presents the CONSORT diagram of the study. 
 
Randomisation 
Following eligibility assessment and consent, the Research Nurse will login to a 
clinical trials coordinating website to obtain an online code for random allocation of patients 
to either the ‘routine care or dressing group’ or the ‘routine care group’. Randomisation will 
involve a stratified approach to ensure even distribution of participants’ diagnostic category 
(medical and surgical), as well as a 1:1 ratio with random block sizes. This method of group 
allocation will ensure concealment of allocation prior to randomisation. 
 
 
Blinding 
As all members of the research team, nursing staff and patient participants will be 
aware of allocation to either the intervention or control group, only the outcome assessor(s) 
will be blinded to group allocation. At each 72 hour point following baseline photograph, a 
high resolution digital photograph will be taken of each participant’s sacrum. De-identified 
and coded photographs will be emailed to blind assessors to ensure they are completely 
removed from the participating wards. 
Two suitably qualified blind assessors have been engaged to evaluate photographs. 
Prior to the commencement of the trial, inter-rater reliability of their PI staging was assessed. 
Further inter-rater assessment of 20 photographs will be undertaken, with the results of each 
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of the two blind assessors compared with an expert assessor from the Stomal Therapy and 
Wound Management Department, a specialist nursing-led service at the participating health 
service. 
 
Data analyses 
Eligible patient and recruitment numbers, participant numbers at each measurement 
wave and attrition data will be reported using a CONSORT style approach (Moher et al. 
2010). Prior to conducting any statistical analysis, variables will be checked for outliers, 
distributional properties, missing values and any observable errors in recording, coding or 
data entry. Sample attrition will be managed via intention-to-treat analysis to ensure an 
unbiased comparison of the groups produced by randomisation. Cohen’s weighted kappa test 
will estimate inter-rater reliability. A score of ≥ 0.7 will be considered acceptable. 
Statistical and clinical comparisons of baseline demographics and clinical 
characteristics will be undertaken to test for any substantial differences between the 
intervention and routine care group. Descriptive results will be reported using summary 
statistics, depending on the level and distribution of the data. Continuous/interval data will be 
expressed as mean ± standard deviation or median ± interquartile range based on normality of 
data and categorical data will be presented as counts and percentages. Analysis will 
specifically address the primary and secondary outcome measures and be performed using 
SPSS version 21. Confidence intervals of 95% will be used for all descriptive tests. 
 
Ethical considerations 
This pilot trial will be conducted in accordance with the Helsinki declaration (2008) 
and [Australian] National Health and Medical Research Council’s National Statement 
Guidelines (2007). Ethical approval has been granted by the health service and university 
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human research ethics committees and proxy consent by family member and/or legal 
guardian approved by the Queensland Civil and Administrative Tribunal. Participants and/or 
their family member or legal guardian will be provided full details of the study purpose, 
benefits and risks and the nature of their potential involvement. Written consent will be 
sought from each patient or their family member or legal guardian prior to randomisation. 
Participants or their family member or legal guardian will be advised that they can withdraw 
from the study at any time and that withdrawal will not jeopardise any treatment or 
relationship with the hospital. Revocation of Consent Forms will be provided to each 
participant as a means of withdrawal. 
There are no reported instances of harm to participants as a result of treatment with 
similar dressings applied to the sacrum (Brindle 2010, Brindle & Wegelin 2012, Chaiken 
2012, Walsh et al. 2012). However several measures have been included in this study to 
ensure patient safety and level of comfort. For example in instances of persistent faecal 
incontinence or identification of a PI on a sacrum of a patient in the intervention group the 
prophylactic dressing will be removed and ongoing care will be provided as per hospital 
policy and reported via the hospital incident reporting process. Furthermore all cases of PI 
and skin reaction in the routine care and dressing group will be reported to the ethics 
committee as adverse events. 
All data will be stored in locked or password protected facilities for 15 years. 
Publications and presentations will be prepared in a manner that maintains the confidentiality 
and anonymity of all study participants. 
This study is registered with the Australian and New Zealand Clinical Trials: 
ACTRN12613001328763 http://www.ANZCTR.org.au/ACTRN12613001328763.aspx 
 
 
15 
 
Validity and reliability / Rigour 
Results from randomised control trials can be useful in drawing conclusions about the 
effects of health care interventions  if appropriate attention is directed  towards ensuring 
validity and reliability of design (random group allocation, allocation concealment and blind 
assessment) and relevance to the population of interest (Rothwell 2006). In this study 
participants will be randomised to group via a random computer-generated process to 
eliminate the possibility of selection bias (Schulz 2008, Kendall 2003). Although 
investigators, clinicians and participants will be aware of group allocation due to the presence 
or absence of a dressing, allocation concealment will be possible via the use of remote blind 
assessors who will evaluate the outcome measurement (assessment of the sacrum) via the use 
of de-identified photography (Kendall 2003, Schulz 2008). 
Careful consideration has been made to target a hospitalised general medical-surgical 
population using a non-probability sampling approach via inclusion and exclusion criteria. 
Data generated for this pilot study will therefore include success of recruitment approaches, 
recruitment rate (number of participants available who meet the eligibility criteria and their 
willingness to participate) and methodological issues related to applying the intervention or 
measuring outcome variables (Kendall 2003). 
As feasibility criteria are being tested, quality control measures in place to reduce 
errors will also be tested. These include the development of a procedure manual, peer 
reviewed data collection forms and documented protocol revisions. All data collected will be 
checked for accuracy and timeliness as identified in the secondary outcomes and analysis 
plan. 
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DISCUSSION 
Although there is considerable evidence to suggest prophylactic dressings are 
effective in reducing the prevalence and severity of PI, it is limited due to its focus on 
intensive care/high dependency patients as well as design constraints related to deficient 
allocation concealment and/or blind assessment. To our knowledge this is the first study to be 
conducted in hospitalised general medical-surgical patients, with both random allocation of 
participants and blind assessment of the primary outcome via the use of photography. 
The general medical-surgical clinical focus of this pilot study is significant. The 
majority of published clinical studies examining the effectiveness of prophylaxis for the 
prevention of PI have been set in critical care contexts (Brindle & Wegelin 2012, Chaiken 
2012, Santamaria et al. 2013, Walsh et al. 2012). These settings are often self-contained and 
specialise in providing concentrated care for immobile critically ill patients characterised by 
one-on-one or high dependency nurse to patient ratios. The success of prophylactic dressings 
in the prevention of PI may therefore be a result of highly controlled patient care. General 
medical-surgical contexts are quite different to critical care settings due to their high patient 
turnover and acuity as well as multiple links to different wards and services. As a result, 
hospital acquired PI in these generalised health environments continues to challenge quality 
outcomes for patients and health services (Allman et al. 1999, VanGilder et al. 2009). 
The unpredictable nature of generalised heath settings necessitated the revision of 
study inclusion criteria. The initial protocol required a risk assessment of PI score using the 
Waterlow scale of 20+ or very high risk. However, early experience in this study and further 
review of evidence related to the assessment of risk of pressure injury (PI) suggests patients 
assessed as very high risk of PI are often critically ill and require intensive care. As this pilot 
study is focused on a different patient population (that is hospitalised general medical-
surgical patients), extending the criteria to include patients with a high, as well as very high 
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risk of developing PI acknowledges the range of health statuses in this population. 
Broadening the Waterlow score for this study also incorporates the recommendation of the 
Waterlow Scale’s creator to use knowledgeable clinical judgement when assessing PI risk 
factors (Waterlow 2005). Thus the inclusion criteria related to the Waterlow score has been 
expanded to include patients assessed as being at high risk of PI or greater (a score of 15+). 
Site of spinal surgery has also been considered when determining the suitability of 
some patients for the study. Patients undergoing lumbar spine surgery cannot have a dressing 
applied to their sacrum as the dressing extends up from the tailbone over the lower back 
covering the surgical incision site. Patients having lower spine surgery are therefore now 
excluded from this pilot study. 
The outcome measurement in many PI prevention studies has not been assessed by a 
blind assessor (Brindle & Wegelin 2012, Chaiken 2012, Santamaria et al. 2013, Walsh et al. 
2012), representing a significant limitation in this body of research. The use of digital 
photography to assess PI therefore represents a practical solution to the problem of blinding 
(Baumgarten et al. 2009) and has demonstrated a high degree of validity for stage 2 PI and 
above (Baumgarten et al. 2009) and inter-rate reliability (Defloor & Schoonhoven 2004). 
There are identified limitations with the use of photographs, particularly in relation to 
detection of stage 1 PI and PI in patients with darkly pigmented skin (Baumgarten et al. 
2009). However limitations associated with assessment of stage 1 PI can also exist with direct 
physical assessment (Australian Wound Management Association 2012). 
 
Limitations 
The Waterlow Scale features frequently in literature relating to PI prevention. While 
some authors have found the tool to be a useful instrument for the evaluation of risk in 
patients (Sayar et al. 2009), others have found it inadequate without independent assessment 
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of the patient’s overall health context (Brindle & Wegelin 2012, Guy 2012, Webster et al. 
2010b). Limitations associated with the scale have been mitigated in this study via purposeful 
clinician judgment based on the patient’s overall health context. 
 
CONCLUSION 
Silicone foam border dressings have been proposed to prevent sacral PI, however 
further rigorous research that includes random group allocation and blind assessment in a 
hospitalised general medical-surgical patient population is needed to establish the benefits of 
combining these dressings with existing routine nursing care in the prevention of PI. This 
study will be the first conducted in a hospitalised general medical-surgical patient population. 
De-identified photographs of participant’s sacrum will be used to enable blind assessment 
and results will inform the feasibility of progressing to a larger definitive RCT. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
19 
 
REFERENCES 
 
Allman, RM , Goode, PS, Burst , N, Bartolucci, AA & Thomas, DR 1999. Pressure Ulcers, Hospital 
Complicat ions and Disease Severity: Impact on Hospital Costs and Length of  Stay. Advances 
in Wound Care, 12, 22-30. 
Armstrong, DG, Ayello, EA, Capitulo, KL, Fowler, E, Krasner, DL, Levine, JM , Sibbald, RG & Adrianne, 
PSS 2008. New Opportunit ies to Improve Pressure Ulcer Prevent ion and Treatment: 
Implicat ions of the CM S Inpat ient  Hospital Care Present on Admission Indicators/ Hospital-
Acquired Condit ions Policy. Advances in Skin & Wound Care, 21, 469. 
Arnold, DM , Adhikari, NK & Cook, D, J. 2009. The design and interpretat ion of  pilot  t rials in clinical 
research in crit ical care. Crit ical Care M edicine, 37, S69-S74. 
Australian Wound M anagement Associat ion 2012. Pan Pacific Clinical Pract ice Guideline for the 
Prevent ion and M anagement of Pressure Injury. Abridged Version, AWM A. Osborne Park, 
WA: Cambridge Print ing  
Baumgarten, M , M argolis, DJ, Selekof, JL, M oye, N, Jones, PS & Shardell, M  2009. Validity of pressure 
ulcer diagnosis using digital photography. Wound Repair and Regeneration, 17, 287-290. 
Bennett , G, Dealey, C & Posnett , J 2004. The cost  of pressure ulcers in the UK. Age and Ageing, 33, 
230-235. 
Brindle, CT 2010. Out liers to the Braden Scale: Ident ifying high-risk ICU pat ients and the result  of  
prophylact ic dressing use. WCET Journal, 11-18. 
Brindle, CT & Wegelin, JA 2012. Prophylact ic Dressing Applicat ion to Reduce Pressure Ulcer 
Format ion in Cardiac Surgery Pat ients. Journal of Wound Ostomy & Cont inence Nursing, 39, 
133-142. 
Centre for Healthcare Improvement 2012. Statewide 2011 pat ient  safety bedside audit  report . 
Brisbane, QLD: Queensland Health. 
Chaiken, N 2012. Reduct ion of Sacral Pressure Ulcers in the Intensive Care Unit  Using a Silicone 
Border Foam Dressing. Journal of Wound Ostomy & Cont inence Nursing, 39, 143145. 
Defloor, T & Schoonhoven, L 2004. Inter-rater reliability of the EPUAP pressure ulcer classificat ion 
system using photographs. Journal of Clinical Nursing, 13, 952-959. 
Gefen, A 2008. How much t ime does it  take to get a pressure ulcer? Integrated evidence from 
human, animal and in vit ro studies. Ostomy Wound M anagement, 54, 26-35. 
Graves, N, Birrell, FA & Whitby, M  2005. M odeling the economic losses from pressure ulcers among 
hospitalized pat ients in Australia. Wound Repair and Regenerat ion, 13, 462-467. 
Guy, H 2012. Pressure ulcer risk assessment. Nursing Times, 108, 16-20. 
20 
 
Hertzog, M A 2008. Considerat ions in determining sample size for pilot  studies. Research in Nursing & 
Health, 31, 180-191. 
Jenkins, M L & O'neal, E 2010. Pressure Ulcer Prevent ion and Incidence in Acute Care. Advances in 
Skin & Wound Care, 23, 556-559. 
Kendall, JM  2003. Designing a research project : randomised controlled t rials and their principles. 
Emergency M edicine Journal, 20, 164-168. 
Lancaster, GA, Dodd, S & Williamson, PR 2004. Design and analysis of pilot  studies: 
recommendat ions for good pract ice. Journal of Evaluat ion in Clinical Pract ice, 10, 307-312. 
Leon, AC, Davis, LL & Kraemer, HC 2011. The role and interpretat ion of pilot  studies in clinical 
research. Journal of Psychiatric Research, 45, 626-629. 
M eyers, TR 2010. Prevent ing Heel Pressure Ulcers and Plantar Flexion Contractures in High-Risk 
Sedated Pat ients. Journal of Wound Ostomy & Cont inence Nursing, 37, 372-378. 
M iles, SJ, Fulbrook, P, Nowicki, T & Franks, C 2013. Decreasing pressure injury prevalence in an 
Australian general hospital: A 10-year review. Wound Pract ice & Research: Journal of the 
Australian Wound M anagement Associat ion, 21, 148-156. 
M oher, D, Hopewell, S, Schulz, KF, M ontori, V, Gøtzsche, PC, Devereaux, PJ, Elbourne, D, Egger, M  &  
Altman, DG 2010. CONSORT 2010 Explanat ion and Elaborat ion: updated guidelines 
for report ing parallel group randomised trials. Journal of Clinical Epidemiology, 63, e1-e37. 
M olnlycke Health Care. M epilex Border Sacrum [Online]. M olnlycke Health Care. Available: 
ht tp:/ / www.molnlycke.com/ au/ Wound-Care-Products/ Product-
selector/ Tabs/ Products/ M epilex-Border-Sacrum/ ?act iveTab=3 [Accessed April 26 2013]. 
M oore, ZEH & Webster, J 2011. Dressing and topical agents for prevent ing pressure ulcers. Cochrane 
Database of Systemat ic Reviews. 
M ulligan, S, Prent ice, J & Scott , L 2011. WoundsWest Wound Prevalence Survey 2011 State-wide 
Overview Report . Perth, WA: Ambulatory Care Services, Department of  Health. 
Nat ional Health and M edical Research Council, ARC, Australian Vice-Chancellor's Commit tee, 2007. 
Nat ional Statement on Ethical Conduct in Human Research. Canberra, ACT: Australian 
Government. 
Nat ional Health Performance Authority 2012. Hospital Performance: Time pat ients spent in 
emergency departments in 2011–12. Nat ional Health Performance Authority. 
Nat ional Pressure Ulcer Advisory Panel (Npuap), EPUaPE 2009. Prevent ion and Treatment of 
Pressure Ulcers: Clinical Pract ice Guideline. Washington DC: NPUAP. 
Rothwell, PM  2006. Factors that  can affect  the external validity of randomised controlled t rials. PLoS 
clinical t rials, 1, e9. 
21 
 
Santamaria, N, Gerdtz, M , Sage, S, M ccann, J, Freeman, A, Vassiliou, T, De Vincent is, S, Ng, AW, 
M anias, E, Liu, W & Knot t , J 2013. A randomised controlled t rial of the effect iveness of soft  
silicone mult i-layered foam dressings in the prevent ion of sacral and heel pressure ulcers in 
t rauma and crit ically ill pat ients: the border t rial. Internat ional Wound Journal, n/ a-n/ a. 
Sayar, A, Turgut , S, Dogan, H & Al., E 2009. Incidence of pressure ulcers in intensive care unit  
pat ients at  risk according to the Waterlow Scale and factors influencing the develoment of 
pressue ulcers. Journal of Clinical Nursing, 18, 765-774. 
Schulz, KF 2008. Assessing allocat ion concealment and blinding in randomised controlled t rials: Why 
bother? In: N. Cullum, DC, R. B. Haynes, S. M arks (ed.) Evidence-Based Nursing: An 
Introduct ion. Blackwell Publishing Ltd, BM J Publishing Group Ltd, RCN Publishing Co Ltd. 
Thabane, L, M a, J, Chu, R, Cheng, J, Ismaila, A, Rios, L, Robson, R, Thabane, M , Giangregorio, L & 
Goldsmith, C 2010. A tutorial on pilot  studies: the what, why and how. BM C M edical 
Research M ethodology, 10, 1. 
Vangilder, C, M acfarlane, G, M eyer, S & Lachenbruch, C 2009. Body M ass Index, Weight and Pressure 
Ulcer Prevalence: An Analysis of the 2006–2007 Internat ional Pressure Ulcer Prevalence™ 
Surveys. Journal of Nursing Care Quality, 24, 127-135. 
Walsh, NS, Blanck, AW, Smith, L, Corss, M  andersson, L & Polito, C 2012. Use of a Sacral Silicone 
Border Foam Dressing as One Component of a Pressure Ulcer Prevention Program in an 
Intensive Care Unit  Sett ing. Journal of Wound Ostomy & Cont inence Nursing, 39, 146-149. 
Waterlow, J 2005. From cost ly t reatment to cost-effect ive prevent ion: using Waterlow. Brit ish 
Journal of Community Nursing, 10, S25. 
Webster, J, Gavin, N, Nicholas, C, Coleman, K & Gardner, G 2010a. Validity of the Waterlow 
screening tool and risks for pressure injusry in acute care. Brit ish Journal of Nursing, 19, S14-
S22. 
Webster, J, Gavin, N & Nicholas, C, Et  Al. 2010b. Validity of the Waterlow scale and risk of pressure 
injury in acute care. Brit ish Journal of Nursing, 9, 14-22. 
Weir, D 2009. Pressure ulcers: assessment, classificat ion and management. In: Krasner, DL, 
Rodeheaver, G.T., Sibbald, R.G. (ed.) Chronic Wound Care: A Clinical Source Book for 
Healthcare Professionals. 4th ed. M alvern, Pennsylvania: HM P Communicat ions. 
 
 
 
 
22 
 
 
 
 
 
 
 
Table 1 Secondary endpoints 
a) Percentage of pat ients who are approached 
b) Percentage of eligible pat ients who meet the eligibility criteria 
c) Percentage of eligible pat ients who do not meet the eligibility criteria and are excluded from 
the study 
d) Percentage of eligible pat ients recruited and consented 
e) Percentage of eligible pat ients who refuse to part icipate (and why they refused) 
f) Percentage of pat ients who are randomised 
g) Percentage of recruited pat ients who complete the study 
h) Percentage of recruited pat ients who do not complete the study 
i) Reasons recruited pat ients were not able to complete the study 
j) Baseline characterist ics of part icipants including age, gender, diagnosis or surgery, site of 
admission, mobility status, body mass index, health comorbidit ies, current smoking status, 
Waterlow score, exist ing PI (other than sacral) and history of PI 
k) Average durat ion (in hours) of applied sacral dressings 
l) Reasons for sacral dressing dislodgement and removal 
m) Patient percept ion of the comfort  of the sacral dressing 
n) Suitability of site including admission points (based on recruitment data, specifically the 
number individuals approached and the number recruited) and chosen wards (based on 
reasons for part icipant non-complet ion data) in the divisions of medicine and surgery 
o) Suitability of t ime and budget allocat ion (based on rate of recruitment, use of dressings and 
judicious budget management) 
p) Effect iveness of preparat ion/  t raining/ support  provided to nursing staff (in part icipat ing 
admission points and wards in the division of medicine and surgery), research nurses and 
blind nurse assessors 
q) Suitability of data collect ion tools for nursing staff, research nurses and blind nurse assessors 
r) Incidence of group allocat ion ident ificat ion by blind assessor 
s) Evaluat ion of inter-rate reliability of PI assessment by blind assessor (based on repeat 
assessment by member of the Stomal Therapy and Wound M anagement Department  
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 Screening and Recruitment of 
pat ient  admit ted to medical 
surgical care set t ings 
 
  
Randomisat ion (N = 80) 
Collect ion of demographic and health status characterist ics, baseline photograph and applicat ion of  
dressing where applicable  
  
Intervent ion group (n = 40) 
Rout ine care + silicone foam border 
dressings  
  Control group (n = 40) 
Rout ine care only 
  
Sacrum/ dressing assessed at  least  once a day and preferably each shift  (every 8 hours) by the 
Research Nurse or RNs caring for the pat ient  as per hospital policy recommendat ions. 
  
At  each 72 hour point  following baseline photograph, a high resolut ion digital photograph taken of 
each part icipant ’s sacrum. 
De-ident ified photographs emailed to blind assessors for evaluat ion 
New dressing applied to intervent ion group part icipants 
 
Figure 1 The CONSORT diagram showing part icipant flow through the study 
 
 
 
